Acute chest pain is a common presentation in emergency departments worldwide. It is a symptom of numerous medical conditions, some benign and others life-threatening. Therefore, a systematic, comprehensive approach to deciphering acute chest pain is essential for healthcare professionals.
The initial evaluation of a patient with acute chest pain should include a detailed history, physical examination, and basic investigations. The history should focus on the character, onset, duration, location, and radiation of the pain. Any associated symptoms, such as shortness of breath, nausea, or sweating, should also be noted. The physical examination should assess the patient's vital signs and include a thorough cardiovascular and respiratory examination.
Basic investigations include a 12-lead electrocardiogram (ECG), chest X-ray, and blood tests for cardiac biomarkers. An ECG can help identify myocardial ischemia or infarction, while a chest X-ray can reveal conditions such as pneumonia or aortic dissection. Elevated cardiac biomarkers, such as troponins, indicate myocardial injury.
Risk stratification is crucial in managing patients with acute chest pain. Tools like the GRACE and TIMI risk scores can help predict the likelihood of adverse cardiac events. Patients at high risk may require immediate intervention, while those at low risk may be suitable for outpatient management.
The management of acute chest pain depends on the underlying cause. For example, myocardial infarction requires urgent revascularization, while stable angina can be managed with lifestyle modifications and medications. Regardless of the cause, all patients should receive education about their condition and advice on when to seek further medical attention.
In conclusion, a comprehensive approach to deciphering acute chest pain involves a thorough history and examination, appropriate investigations, risk stratification, and tailored management. This approach can help healthcare professionals accurately diagnose and effectively manage this common, but potentially serious, symptom.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation